Acasti Pharma Inc (NAS:ACST)
$ 3.3 0.15 (4.76%) Market Cap: 31.02 Mil Enterprise Value: 5.93 Mil PE Ratio: 0 PB Ratio: 0.48 GF Score: 41/100

Q2 2020 Acasti Pharma Inc Earnings Call Transcript

Nov 13, 2019 / 06:00PM GMT
Release Date Price: $98.88 (-3.29%)
Operator

Good day, ladies and gentlemen, and welcome to the Acasti Pharma Second Quarter 2020 Business Update Conference Call. (Operator Instructions) At this time, it's my pleasure to turn the floor over to Mr. David Waldman, Investor Relations. Sir, the floor is yours.

David K. Waldman
Crescendo Communications, LLC - President & CEO

Thank you. Good afternoon, everyone, and welcome to Acasti Pharma's Second Quarter Fiscal 2020 Conference Call. On the call with us this afternoon are Jan D' Alvise, President and CEO; Pierre Lemieux, Chief Operating Officer, Chief Scientific Officer and Co-Founder; Brian Groch, Chief Commercial Officer; and Jean-François Boily, Vice President, Finance.

If you have any questions after the call or would like any additional information about the company, please contact Crescendo Communications at (212) 671-1020.

I'd also like to remind everyone that statements on this conference call that are not statements of historical or current facts constitute forward-looking information within the meaning of the Canadian

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot